Literature DB >> 24219236

Mitigation of ROS insults by Streptomyces secondary metabolites in primary cortical neurons.

Marta Leirós1, Eva Alonso, Jon A Sanchez, Mostafa E Rateb, Rainer Ebel, Wael E Houssen, Marcel Jaspars, Amparo Alfonso, Luis M Botana.   

Abstract

Oxidative stress is a common point in neurodegenerative diseases, widely connected with mitochondrial dysfunction. In this study, we screened seven natural products from Streptomyces sources against hydrogen peroxide insult in primary cortical neurons, an oxidative stress in vitro model. We showed the ability of these compounds to inhibit neuronal cytotoxicity and to reduce ROS release after 12 h treatment. Among the tested compounds, the quinone anhydroexfoliamycin and the red pyrrole-type pigment undecylprodigiosin stand out. These two compounds displayed the most complete protection against oxidative stress with mitochondrial function improvement, ROS production inhibition, and increase of antioxidant enzyme levels, glutathione and catalase. Further investigations confirmed that anhydroexfoliamycin acts over the Nrf2-ARE pathway, as a Nrf2 nuclear translocation inductor, and is able to strongly inhibit the effect of the mitochondrial uncoupler FCCP over cytosolic Ca(2+), pointing to mitochondria as a cellular target for this molecule. In addition, both compounds were able to reduce caspase-3 activity induced by the apoptotic enhancer staurosporine, but undecylprodigiosin failed to inhibit FCCP effects and it did not act over the Nrf2 pathway as was the case for anhydroexfoliamycin. These results show that Streptomyces metabolites could be useful for the development of new drugs for prevention of neurodegenerative disorders such as Parkinson's and Alzheimer's diseases and cerebral ischemia.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24219236      PMCID: PMC3894724          DOI: 10.1021/cn4001878

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  54 in total

1.  Benzastatins H and I, new benzastatin derivatives with neuronal cell protecting activity from Streptomyces nitrosporeus.

Authors:  W G Kim; I J Ryoo; J S Park; I D Yoo
Journal:  J Antibiot (Tokyo)       Date:  2001-06       Impact factor: 2.649

2.  Desferrioxamine E produced by Streptomyces griseus stimulates growth and development of Streptomyces tanashiensis.

Authors:  Kazuki Yamanaka; Hiroaki Oikawa; Hiro-Omi Ogawa; Kuniaki Hosono; Fumie Shinmachi; Hideaki Takano; Shohei Sakuda; Teruhiko Beppu; Kenji Ueda
Journal:  Microbiology       Date:  2005-09       Impact factor: 2.777

Review 3.  The Nrf2-ARE pathway: a valuable therapeutic target for the treatment of neurodegenerative diseases.

Authors:  Gururaj Joshi; Jeffrey A Johnson
Journal:  Recent Pat CNS Drug Discov       Date:  2012-12

4.  Diverse metabolic profiles of a Streptomyces strain isolated from a hyper-arid environment.

Authors:  Mostafa E Rateb; Wael E Houssen; William T A Harrison; Hai Deng; Chinyere K Okoro; Juan A Asenjo; Barbara A Andrews; Alan T Bull; Michael Goodfellow; Rainer Ebel; Marcel Jaspars
Journal:  J Nat Prod       Date:  2011-08-31       Impact factor: 4.050

Review 5.  Antioxidants, oxidative stress, and degenerative neurological disorders.

Authors:  R A Floyd
Journal:  Proc Soc Exp Biol Med       Date:  1999-12

6.  Prodigiosin isolated from Hahella chejuensis suppresses lipopolysaccharide-induced NO production by inhibiting p38 MAPK, JNK and NF-kappaB activation in murine peritoneal macrophages.

Authors:  Jung-Eun Huh; Joung-Han Yim; Hong-Kum Lee; Eun-Yi Moon; Dong-Kwon Rhee; Suhkneung Pyo
Journal:  Int Immunopharmacol       Date:  2007-10-01       Impact factor: 4.932

7.  Akt downregulation by flavin oxidase-induced ROS generation mediates dose-dependent endothelial cell damage elicited by natural antioxidants.

Authors:  Valeria Pasciu; Anna Maria Posadino; Annalisa Cossu; Bastiano Sanna; Bruna Tadolini; Leonardo Gaspa; Andrea Marchisio; Salvatore Dessole; Giampiero Capobianco; Gianfranco Pintus
Journal:  Toxicol Sci       Date:  2009-12-15       Impact factor: 4.849

Review 8.  The prodigiosins: a new family of anticancer drugs.

Authors:  Beatriz Montaner; Ricardo Pérez-Tomás
Journal:  Curr Cancer Drug Targets       Date:  2003-02       Impact factor: 3.428

Review 9.  Flavonoids, cognition, and dementia: actions, mechanisms, and potential therapeutic utility for Alzheimer disease.

Authors:  Robert J Williams; Jeremy P E Spencer
Journal:  Free Radic Biol Med       Date:  2011-09-17       Impact factor: 7.376

Review 10.  Antioxidant therapies for Alzheimer's disease.

Authors:  Ye Feng; Xiaochuan Wang
Journal:  Oxid Med Cell Longev       Date:  2012-07-25       Impact factor: 6.543

View more
  10 in total

Review 1.  The Keap1-Nrf2 pathway: promising therapeutic target to counteract ROS-mediated damage in cancers and neurodegenerative diseases.

Authors:  Prashant Deshmukh; Sruthi Unni; Gopinatha Krishnappa; Balasundaram Padmanabhan
Journal:  Biophys Rev       Date:  2016-12-06

Review 2.  Nrf2 Weaves an Elaborate Network of Neuroprotection Against Stroke.

Authors:  Shuai Jiang; Chao Deng; Jianjun Lv; Chongxi Fan; Wei Hu; Shouyin Di; Xiaolong Yan; Zhiqiang Ma; Zhenxing Liang; Yang Yang
Journal:  Mol Neurobiol       Date:  2016-02-05       Impact factor: 5.590

Review 3.  Anti-Alzheimer's Molecules Derived from Marine Life: Understanding Molecular Mechanisms and Therapeutic Potential.

Authors:  Md Tanvir Kabir; Md Sahab Uddin; Philippe Jeandet; Talha Bin Emran; Saikat Mitra; Ghadeer M Albadrani; Amany A Sayed; Mohamed M Abdel-Daim; Jesus Simal-Gandara
Journal:  Mar Drugs       Date:  2021-04-28       Impact factor: 5.118

Review 4.  Biotechnological applications derived from microorganisms of the Atacama Desert.

Authors:  Armando Azua-Bustos; Carlos González-Silva
Journal:  Biomed Res Int       Date:  2014-07-23       Impact factor: 3.411

Review 5.  Natural products targeting mitochondria: emerging therapeutics for age-associated neurological disorders.

Authors:  Zhibin Liang; Antonio Currais; David Soriano-Castell; David Schubert; Pamela Maher
Journal:  Pharmacol Ther       Date:  2020-11-20       Impact factor: 12.310

6.  Streptomyces antioxidans sp. nov., a Novel Mangrove Soil Actinobacterium with Antioxidative and Neuroprotective Potentials.

Authors:  Hooi-Leng Ser; Loh Teng-Hern Tan; Uma D Palanisamy; Sri N Abd Malek; Wai-Fong Yin; Kok-Gan Chan; Bey-Hing Goh; Learn-Han Lee
Journal:  Front Microbiol       Date:  2016-06-16       Impact factor: 5.640

Review 7.  Drought Stress and Root-Associated Bacterial Communities.

Authors:  Dan Naylor; Devin Coleman-Derr
Journal:  Front Plant Sci       Date:  2018-01-09       Impact factor: 5.753

8.  Functional Recovery of Contused Spinal Cord in Rat with the Injection of Optimal-Dosed Cerium Oxide Nanoparticles.

Authors:  Jong-Wan Kim; Chinmaya Mahapatra; Jin-Young Hong; Min Soo Kim; Kam W Leong; Hae-Won Kim; Jung Keun Hyun
Journal:  Adv Sci (Weinh)       Date:  2017-07-08       Impact factor: 16.806

9.  Streptomyces-Derived Metabolites with Potential Photoprotective Properties-A Systematic Literature Review and Meta-Analysis on the Reported Chemodiversity.

Authors:  Jeysson Sánchez-Suárez; Ericsson Coy-Barrera; Luisa Villamil; Luis Díaz
Journal:  Molecules       Date:  2020-07-15       Impact factor: 4.411

10.  Anhydroexfoliamycin, a Streptomyces Secondary Metabolite, Mitigates Microglia-Driven Inflammation.

Authors:  Sandra Gegunde; Amparo Alfonso; Rebeca Alvariño; Nadia Pérez-Fuentes; Luis M Botana
Journal:  ACS Chem Neurosci       Date:  2021-06-10       Impact factor: 4.418

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.